| 000 | 01891 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516004611.0 | ||
| 264 | 0 | _c20110315 | |
| 008 | 201103s 0 0 eng d | ||
| 022 | _a1878-1705 | ||
| 024 | 7 |
_a10.1016/j.intimp.2010.09.017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Biing-Hui | |
| 245 | 0 | 0 |
_aThe fungal metabolite, citrinin, inhibits lipopolysaccharide/interferon-γ-induced nitric oxide production in glomerular mesangial cells. _h[electronic resource] |
| 260 |
_bInternational immunopharmacology _cDec 2010 |
||
| 300 |
_a1608-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Nucleus _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCitrinin _xisolation & purification |
| 650 | 0 | 4 |
_aCytosol _xdrug effects |
| 650 | 0 | 4 | _aElectrophoretic Mobility Shift Assay |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 |
_aImmunologic Factors _xisolation & purification |
| 650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aMesangial Cells _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMonascus _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNitric Oxide Synthase Type II _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 700 | 1 | _aChi, Jhih-Ying | |
| 700 | 1 | _aHsiao, Yu-Wei | |
| 700 | 1 | _aTsai, Kuen-Daw | |
| 700 | 1 | _aLee, Yi-Ju | |
| 700 | 1 | _aLin, Chia-Ching | |
| 700 | 1 | _aHsu, Shu-Ching | |
| 700 | 1 | _aYang, Shu-Mei | |
| 700 | 1 | _aLin, Ting-Hui | |
| 773 | 0 |
_tInternational immunopharmacology _gvol. 10 _gno. 12 _gp. 1608-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2010.09.017 _zAvailable from publisher's website |
| 999 |
_c20241367 _d20241367 |
||